Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gabriel Dan Duda, D.M.D., Ph.D.

Concepts (587)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Gabriel Dan Duda's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Gabriel Dan Duda has written about over time.
Neovascularization, Pathologic, 45 publications between 2000 and 2022, average publication date August 2010. Vascular Endothelial Growth Factor Receptor-1, 14 publications between 2002 and 2019, average publication date November 2011. Quinazolines, 15 publications between 2007 and 2017, average publication date March 2012. Vascular Endothelial Growth Factor A, 41 publications between 2002 and 2022, average publication date October 2012. Angiogenesis Inhibitors, 43 publications between 2000 and 2022, average publication date January 2013. Vascular Endothelial Growth Factor Receptor-2, 12 publications between 2003 and 2019, average publication date November 2013. Glioblastoma, 23 publications between 2007 and 2020, average publication date April 2014. Receptors, CXCR4, 10 publications between 2009 and 2022, average publication date October 2014. Niacinamide, 6 publications between 2012 and 2020, average publication date October 2015. Antineoplastic Combined Chemotherapy Protocols, 22 publications between 2005 and 2023, average publication date December 2015. Phenylurea Compounds, 8 publications between 2012 and 2020, average publication date July 2016. Immunotherapy, 15 publications between 2009 and 2022, average publication date May 2017. Liver Neoplasms, 41 publications between 2001 and 2023, average publication date December 2017. Tumor Microenvironment, 23 publications between 2012 and 2023, average publication date February 2018. Carcinoma, Hepatocellular, 35 publications between 2009 and 2023, average publication date April 2018. Cholangiocarcinoma, 8 publications between 2013 and 2022, average publication date May 2018. Bile Duct Neoplasms, 7 publications between 2013 and 2022, average publication date May 2018.

To see the data from this visualization as text, click here.
Duda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (587)
Explore
_
Co-Authors (176)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.